Short answer · Medically reviewed summary · Last updated: 2026-05-08
Palindromic Rheumatism was first clinically defined in 1944 by Dr. Philip Hench and Dr.
2 people with Palindromic Rheumatism have shared their first-person experience on this question at DiseaseMaps.
What is the history of Palindromic Rheumatism?
History of Palindromic Rheumatism: when and how it was discovered, and the milestones in research since, medically reviewed.
Palindromic Rheumatism was first clinically defined in 1944 by Dr. Philip Hench and Dr. Edward Rosenberg, who characterized it as a distinct, recurring pattern of acute arthritis and periarthritis. While historically viewed as an enigmatic "benign" condition, medical understanding has shifted to recognize Palindromic Rheumatism as a potential precursor to chronic inflammatory diseases like rheumatoid arthritis.
When was Palindromic Rheumatism first described?
The medical literature formally introduced Palindromic Rheumatism in 1944 through the seminal work of Dr. Philip Hench and Dr. Edward Rosenberg at the Mayo Clinic. They observed a group of patients experiencing sudden, fleeting attacks of joint swelling and pain that would resolve completely between episodes, a phenomenon they termed "palindromic" due to its recurring nature. Before this, these episodes were often misdiagnosed as localized trauma or gout.
How has the understanding of Palindromic Rheumatism evolved?
For decades, Palindromic Rheumatism was considered a rare, isolated entity. However, longitudinal studies have corrected the misconception that it is always benign. Clinical research now suggests that 30-50% of patients diagnosed with Palindromic Rheumatism will eventually transition to rheumatoid arthritis (RA). This realization has fundamentally changed the clinical approach from "wait and see" to early, aggressive intervention.
Key milestones in the history of Palindromic Rheumatism treatment
The management of Palindromic Rheumatism has moved from simple symptom management to targeted immune modulation. Historical milestones include:
- The Pre-Biologic Era: Initial reliance on NSAIDs and aspirin to manage acute, episodic pain.
- Introduction of DMARDs: The adoption of hydroxychloroquine (Plaquenil) and methotrexate as standard preventative therapies to reduce the frequency of flares.
- Genetic Insights: Modern testing for Rheumatoid Factor (RF) and anti-CCP antibodies has allowed physicians to better stratify which patients with Palindromic Rheumatism are at higher risk of progressing to systemic RA.
How has patient advocacy changed the landscape?
Early patients often faced skepticism due to the "invisible" nature of Palindromic Rheumatism between flares. Today, platforms like DiseaseMaps.org, which hosts a community of 96 people with Palindromic Rheumatism, have empowered patients to document their experiences, bridging the gap between clinical observation and lived reality.
Next steps
- Consult a board-certified rheumatologist to discuss a proactive treatment plan.
- Maintain a detailed symptom journal to track flare frequency and duration.
- Join the DiseaseMaps.org community to connect with others sharing similar experiences.
Medical Disclaimer: This content is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: Rare Disease Database
- PubMed: Landmark 1944 studies on Palindromic Rheumatism
- American College of Rheumatology (ACR) clinical guidelines
https://www.hopkinsarthritis.org/physician-corner/rheumatology-rounds/round-1-palindromic-rheumatism
Posted Oct 12, 2017 by Betty 200
In the early years and even now, there's still debate over its separation from RA. While most medical organizations seem to separate the two, the many similarities between the conditions leave some researchers and physicians lumping the two diseases together.
Posted Dec 1, 2019 by MaddOryxite 3570
